Companion Diagnostics Market
Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy.
Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Companion</strong> <strong>Diagnostics</strong> <strong>Market</strong>-<br />
INDUSTRYINSIGHTS, TRENDS, OUTLOOK, AND<br />
OPPORTUNITY ANALYSIS, 2016–2024<br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Companion</strong> <strong>Diagnostics</strong> <strong>Market</strong>: Overview<br />
The Global <strong>Companion</strong> <strong>Diagnostics</strong> (CDx) <strong>Market</strong> was valued at US$ 1,614.5<br />
million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast<br />
period (2016–2024), as highlighted in a new report published by Coherent <strong>Market</strong><br />
Insights. Development of multiple biomarkers and targeted drug therapy is boosting<br />
research and development collaboration among the industry players. This is<br />
expected to improve the time to market for companion diagnostic (CDx) test<br />
products.<br />
The U.S. FDA lays emphasis on regulatory clearance of companion diagnostics, in<br />
its recent draft guidance in 2016, before approving any oncology product that<br />
requires and in-vitro diagnostic (IVD) companion diagnostic device for tis safe and<br />
effective use. Therefore, drug developers and diagnostic test manufacturers need to<br />
work in close collaborations in order to avoid any regulatory bottlenecks.<br />
AstraZeneca plc struck a deal with Abbott Laboratories, Inc. in 2015 to develop a<br />
companion diagnostic test for tralokinumab, used for treating severe asthma. If<br />
successful, this would be the first companion diagnostic test developed for asthma.<br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Companion</strong> <strong>Diagnostics</strong> <strong>Market</strong>: Taxonomy<br />
This report segments the global companion diagnostics market on the basis of<br />
application, technology, and geography. On the basis of application, the market is<br />
categorized into breast cancer, lung cancer, colorectal cancer, gastric cancer,<br />
melanoma, and others. On the basis of technology, the market is segmented into<br />
immunohistochemistry, real-time PCR, gene sequencing, Fluorescence in situ<br />
hybridization (FISH), and others. For comprehensive understanding of market<br />
dynamics, the global companion diagnostics market is analyzed across key<br />
geographical regions namely North America, Europe, Asia Pacific, Latin America,<br />
Africa, and Middle East. Each of these regions is analyzed on basis of market<br />
findings across major countries in these regions for a macro-level understanding of<br />
the market.<br />
Request Free Report Sample @<br />
https://www.coherentmarketinsights.com/insight/request-sample/109<br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Companion</strong> <strong>Diagnostics</strong> <strong>Market</strong> : Key Players<br />
●<br />
●<br />
●<br />
●<br />
●<br />
●<br />
●<br />
●<br />
●<br />
Abbott Laboratories Inc.<br />
Agilent Technologies, Inc.<br />
Danaher Corporation<br />
GE Healthcare, Qiagen N.V.<br />
Roche <strong>Diagnostics</strong><br />
Myriad Genetics, Inc.<br />
bioMérieux SA<br />
Illumina, Inc.<br />
Siemens Healthcare<br />
Get More Details About This Report@<br />
https://www.coherentmarketinsights.com/market-insight/companiondiagnostics-market-109<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
ABOUT US<br />
Coherent <strong>Market</strong> Insights is a global market intelligence and consulting<br />
organization focused on assisting its plethora of clients achieve transformational<br />
growth by helping them make critical business decisions. We are headquartered in<br />
India, with an office at the global financial capital in the U.S. Our client base<br />
includes players from across all business verticals in over 150 countries worldwide.<br />
We are uniquely positioned to help businesses around the globe deliver practical<br />
and lasting results through various recommendations about operational<br />
improvements, technologies, emerging market trends and new working methods.<br />
We offer both customized and syndicated market research reports that help our<br />
clients create visionary growth plans to provide traction to their business. We<br />
meticulously study emerging trends across various industries at both the global and<br />
regional levels to identify new opportunities for our clientele.<br />
SERVICES<br />
INDUSTRY ANALYSIS<br />
MARKET INTELLIGENCE<br />
SERVICES<br />
CUSTOMIZED<br />
RESEARCH<br />
CONSULT STUDIES<br />
SYNDICATED RESEARCH<br />
COUNTRY SPECIFIC<br />
STUDIES<br />
© Coherent market Insights. All Rights Reserved
ABOUT CMI<br />
SECTOR<br />
COVERAGE<br />
BIOTECHNOLOGY<br />
CLINICAL<br />
DIAGNOSTIC<br />
HEALTHCARE IT<br />
MEDICAL DEVICES<br />
MEDICAL IMAGING<br />
PHARMACEUTICAL<br />
OUR CLIENTS<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Global Leading Equipment and System Manufacturers<br />
Component Providers and System Integrators<br />
Distributors, Retailors and Value Added Resellers<br />
Healthcare IT Solutions Developers<br />
<strong>Market</strong>ing Consultancies and the Advertising Industry<br />
Private and Government organization<br />
Outsourcing Companies<br />
Universities and Business Schools.<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
KEY STATS<br />
RESEARCH SOLUTIONS<br />
FEASIBILITY<br />
STUDIES<br />
GLOBAL<br />
REPORTS<br />
100+<br />
Insights Published Per<br />
Year<br />
150+<br />
Consulting Projects Till Date<br />
125+<br />
Clients Worldwide Per Year<br />
CONSULT<br />
PROJECTS<br />
SURVEY<br />
RESEAR<br />
CH<br />
EXCEL<br />
FORECAST<br />
DATABASE<br />
COUNTRY<br />
ANALYSIS<br />
COMPETITIVE<br />
ASSESSMENT<br />
110+<br />
TECHNOLOGY<br />
SNIPPETS<br />
Analysts and Contract Consultants<br />
Coherent <strong>Market</strong> Insights excels at offering unmatched actionable market intelligence across various industry verticals, including<br />
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in<br />
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various<br />
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely<br />
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed<br />
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.<br />
© Coherent market Insights. All Rights Reserved
THANK YOU<br />
To know more about us, visit our website:<br />
www.coherentmarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@coherentmarketinsights.com<br />
For other queries contact:<br />
Mr. Shah<br />
(Manager - Business Development)<br />
Coherent <strong>Market</strong> Insights<br />
sales@coherentmarketinsights.com<br />
+1-206-701-6702<br />
© Coherent market Insights. All Rights Reserved
Change language